학술논문
Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study
Document Type
Article
Author
Source
In The Lancet Global Health February 2024 12(2):e282-e291
Subject
Language
ISSN
2214-109X